Bukwang Pharm (003000) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Based on the latest financial reports, Bukwang Pharm (003000) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-6.24 Billion ≈ $-4.23 Million USD) by net assets (₩340.83 Billion ≈ $230.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Bukwang Pharm's balance sheet to measure how much of total assets are equity-financed.

Bukwang Pharm - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Bukwang Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Bukwang Pharm's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Bukwang Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bukwang Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ningbo GQY Video Telecom SHE:300076	-0.014x
Twin Disc Incorporated NASDAQ:TWIN	0.028x
Putnam Managed Municipal Income Closed Fund NYSE:PMM	0.036x
Nanjing Huamai Tech Co Ltd SHG:603042	-0.004x
Galan Lithium Ltd AU:GLN	-0.008x
Weifu High Tech Group SHE:200581	0.049x
Immuneering Corp NASDAQ:IMRX	-0.053x
Windsor Machines Limited NSE:WINDMACHIN	-0.057x

Annual Cash Flow Conversion Efficiency for Bukwang Pharm (2007–2024)

The table below shows the annual cash flow conversion efficiency of Bukwang Pharm from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Bukwang Pharm.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩244.15 Billion ≈ $165.45 Million	₩34.36 Billion ≈ $23.29 Million	0.141x	+452.19%
2023-12-31	₩234.26 Billion ≈ $158.76 Million	₩-9.36 Billion ≈ $-6.34 Million	-0.040x	-165.99%
2022-12-31	₩271.85 Billion ≈ $184.23 Million	₩16.46 Billion ≈ $11.16 Million	0.061x	-36.06%
2021-12-31	₩280.06 Billion ≈ $189.79 Million	₩26.52 Billion ≈ $17.98 Million	0.095x	+3451.72%
2020-12-31	₩271.19 Billion ≈ $183.78 Million	₩723.17 Million ≈ $490.08K	0.003x	+103.72%
2019-12-31	₩326.49 Billion ≈ $221.25 Million	₩-23.41 Billion ≈ $-15.86 Million	-0.072x	-534.85%
2018-12-31	₩413.44 Billion ≈ $280.18 Million	₩6.82 Billion ≈ $4.62 Million	0.016x	-59.31%
2017-12-31	₩211.30 Billion ≈ $143.20 Million	₩8.56 Billion ≈ $5.80 Million	0.041x	+212.04%
2016-12-31	₩214.63 Billion ≈ $145.45 Million	₩-7.76 Billion ≈ $-5.26 Million	-0.036x	-179.08%
2015-12-31	₩225.15 Billion ≈ $152.58 Million	₩10.30 Billion ≈ $6.98 Million	0.046x	-65.53%
2014-12-31	₩210.00 Billion ≈ $142.31 Million	₩27.86 Billion ≈ $18.88 Million	0.133x	-26.94%
2013-12-31	₩201.07 Billion ≈ $136.26 Million	₩36.52 Billion ≈ $24.75 Million	0.182x	+11.16%
2007-12-31	₩170.63 Billion ≈ $115.63 Million	₩27.87 Billion ≈ $18.89 Million	0.163x	--

About Bukwang Pharm

KO:003000 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$266.79 Million

₩393.67 Billion KRW

Market Cap Rank

#15272 Global

#489 in Korea

Share Price

₩3990.00

Change (1 day)

+6.40%

52-Week Range

₩3255.00 - ₩9600.00

All Time High

₩36947.85